Collection Risk From Deteriorating Counterparty Conditions or Unsuccessful Medical Support
First written in FY2024. 3 of 4 entries say "Materialised", first in FY2026-H1. Latest entry: 2026-08-14.
Amvis Holdings moved to the "Worse" side of this theme in 2026, 1 year after the typical company in this theme (2025).
0 other companies' latest entry also says "Materialised".
- FY2026-H1MaterialisedAnnual report
「Revenue was ¥569 million, up 149.6% year on year, due mainly to an increase of 2 in the number of medical institutions receiving management support and progress in expanding the services provided to existing supported institutions. Meanwhile, the Company recorded an ¥81 million provision for doubtful accounts for certain counterparties.」
While the number of supported medical institutions increased by 2 and support services were expanded, the Company recorded an ¥81 million provision for doubtful accounts for certain counterparties, indicating that collection risk has materialized in the accounting treatment. - FY2024First statedAnnual report
「If the credit standing of a counterparty deteriorates or management support proves unsuccessful, collection of fees receivable by the Group or funds provided by the Group may be delayed, or bad debt losses may arise.」
In connection with providing management and financial support to medical corporations in the medical support business, the Company has newly identified the risks of deteriorating counterparty credit, unsuccessful support, delayed collection of fees and funds, and bad debt losses.